prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 266
2019
-
High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade During Ibrutinib Therapy in Patients with CLL.
Year: 2019, type: Conference abstract
-
High surface tumor IgM levels associate with reduced response duration and with BTK bypass during ibrutinib therapy in CLL patients
Year: 2019, type: Conference abstract
-
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience
Leukemia Research, year: 2019, volume: 81, edition: JUN 2019, DOI
-
Jak vlastně fungují anti CD 20 monoklonální protilátky? Víme více po 20 letech jejich používání?
Year: 2019, type: Conference abstract
-
Komplexní mechanismy účinku inhibitorů „BCR signalizace“ a vzniku rezistence na tuto cílenou léčbu u chronické lymfocytární leukemie
Transfúze a hematologie dnes, year: 2019, volume: 25, edition: 4
-
Mechanism of leukemia cell adaptation to targeted therapy in chronic lymphocytic leukemia
Year: 2019, type: Conference abstract
-
MicroRNA a regulace BCR signalizace u B buněčných malignit: Biomarkery a terapeutické implikace.
Year: 2019, type: Conference abstract
-
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells
Leukemia, year: 2019, volume: 33, edition: 2, DOI
-
Nové mechanismy regulace B buněčné signalizace u leukémií a lymfomů.
Year: 2019, type: Conference abstract
-
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
Haematologica, year: 2019, volume: 104, edition: 12, DOI